Bard Associates Inc. maintained its position in shares of The Joint Corp. (NASDAQ:JYNT) during the second quarter, according to the company in its most recent filing with the SEC. The firm owned 66,950 shares of the company’s stock at the close of the second quarter. Bard Associates Inc. owned 0.51% of The Joint Corp. worth $254,000 as of its most recent filing with the SEC.

Other large investors also recently bought and sold shares of the company. White Pine Capital LLC increased its holdings in shares of The Joint Corp. by 44.2% during the 2nd quarter. White Pine Capital LLC now owns 55,500 shares of the company’s stock worth $211,000 after purchasing an additional 17,000 shares during the period. Russell Investments Group Ltd. increased its holdings in shares of The Joint Corp. by 3.8% during the 1st quarter. Russell Investments Group Ltd. now owns 70,400 shares of the company’s stock worth $296,000 after purchasing an additional 2,600 shares during the period. Boston Partners increased its holdings in shares of The Joint Corp. by 13.1% during the 2nd quarter. Boston Partners now owns 150,900 shares of the company’s stock worth $573,000 after purchasing an additional 17,500 shares during the period. Finally, Sanders Morris Harris LLC increased its holdings in shares of The Joint Corp. by 0.5% during the 2nd quarter. Sanders Morris Harris LLC now owns 2,619,807 shares of the company’s stock worth $9,955,000 after purchasing an additional 12,000 shares during the period. Institutional investors own 47.03% of the company’s stock.

Several research analysts have recently issued reports on the stock. ValuEngine upgraded shares of The Joint Corp. from a “sell” rating to a “hold” rating in a report on Tuesday, June 6th. Zacks Investment Research downgraded shares of The Joint Corp. from a “hold” rating to a “sell” rating in a report on Wednesday, May 17th. Craig Hallum assumed coverage on shares of The Joint Corp. in a report on Wednesday, June 14th. They set a “buy” rating and a $5.75 price objective on the stock. Maxim Group restated a “buy” rating and set a $7.00 price objective on shares of The Joint Corp. in a report on Friday, August 11th. Finally, Roth Capital started coverage on shares of The Joint Corp. in a report on Thursday, July 27th. They set a “buy” rating and a $5.70 price objective on the stock. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $5.61.

In other The Joint Corp. news, Director James H. Amos, Jr. acquired 10,000 shares of the company’s stock in a transaction on Friday, June 30th. The stock was acquired at an average price of $3.85 per share, for a total transaction of $38,500.00. Following the purchase, the director now directly owns 57,295 shares of the company’s stock, valued at $220,585.75. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO John P. Meloun acquired 6,850 shares of the company’s stock in a transaction on Tuesday, June 27th. The stock was acquired at an average price of $3.69 per share, with a total value of $25,276.50. The disclosure for this purchase can be found here. Insiders acquired a total of 20,670 shares of company stock valued at $78,140 in the last quarter. Corporate insiders own 6.10% of the company’s stock.

Shares of The Joint Corp. (JYNT) opened at 4.98 on Wednesday. The company’s market cap is $65.63 million. The company has a 50-day moving average of $4.00 and a 200-day moving average of $3.90. The Joint Corp. has a 1-year low of $1.96 and a 1-year high of $5.07.

The Joint Corp. (NASDAQ:JYNT) last issued its quarterly earnings data on Thursday, August 10th. The company reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.01. The Joint Corp. had a negative net margin of 48.08% and a negative return on equity of 103.25%. The business had revenue of $6.02 million during the quarter, compared to analysts’ expectations of $5.76 million. Equities analysts forecast that The Joint Corp. will post ($0.33) EPS for the current year.

TRADEMARK VIOLATION WARNING: “The Joint Corp. (JYNT) Holdings Maintained by Bard Associates Inc.” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.thecerbatgem.com/2017/09/13/the-joint-corp-jynt-holdings-maintained-by-bard-associates-inc.html.

The Joint Corp. Company Profile

The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention.

Institutional Ownership by Quarter for The Joint Corp. (NASDAQ:JYNT)

Receive News & Stock Ratings for The Joint Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Joint Corp. and related stocks with our FREE daily email newsletter.